Completed PHASE4 INTERVENTIONAL 2-arm NCT03120637

Evaluating in Cirrhotics With Refractory Vasoplegia the Effect of Methylene Blue (CRuMBS)

Evaluating in Cirrhotics With Refractory Vasoplegia the Effect of Methylene Blue in Sepsis: A Randomized Controlled Trial

Sponsor: Institute of Liver and Biliary Sciences, India

Conditions Cirrhosis, Liver Refractory Shock Septic Shock Vasoplegia

Interventions Methylene Blue

Updated 6 times since 2017 Last updated: Jan 29, 2018 Started: Jan 1, 2017 Primary completion: Jan 10, 2018 Completion: Jan 10, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Cirrhosis, Liver and Refractory Shock, this trial is completed. The trial is conducted by Institute of Liver and Biliary Sciences, India and has accumulated 6 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Feb 2018 — Jun 2018 [monthly]

Completed PHASE4

Status: Recruiting → Completed

▶ Show 1 earlier version

May 2017 — Feb 2018 [monthly]

Recruiting PHASE4

First recorded

Jan 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Institute of Liver and Biliary Sciences, India

Data source: Institute of Liver and Biliary Sciences, India

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• New Delhi, India